GEBELİK VE LAKTASYON DÖNEMİNDE COVID 19 ENFEKSİYONUNA KARŞI AŞILAMA: KISA BİR DEĞERLENDİRME

Öz

Amaç: Aşılama, Covid 19 enfeksiyonuna karşı korunmada hayati rol oynamaktadır. Bununla birlikte, gebe ve emziren kadınlar aşının anne adayı, fetüs ve bebek üzerindeki bilinmeyen etkileri nedeniyle aşıların klinik denemelerinin dışında tutulmaktadır. Gebelik ve onu takip eden laktasyon dönemleri, anne ve bebek için pek çok uygulamanın tartışıldığı, kendine has fizyolojik, psikolojik ve patolojik özellikleri olan uzun bir süreçtir. Aşı türlerinin etki mekanizmalarına ilişkin mevcut sınırlı verilere dayanarak, Covid 19 aşılarının hamile kadınlar ve emziren anneler için herhangi bir risk oluşturması muhtemel değildir. Öte yandan, şu anda hamile ve emziren kadınlarda Covid 19 aşılarının güvenliğine ilişkin yeterli veri bulunmamaktadır. Sonuç ve Tartışma: Hamile ve emziren kadınların aşılar hakkında karar vermesini desteklemek için aşılar hakkında kanıta dayalı ve kişiselleştirilmiş bilgilere ihtiyaç vardır. Tüm gebe ve emziren kadınlara Covid 19 aşılarının yararları ve riskleri hakkında yeterince bilgi verildikten ve onamları alındıktan sonra aşı önerilmelidir. Bu bağlamda bu kısa derleme gebelik ve laktasyon döneminde Covid 19 enfeksiyonuna karşı aşılamanın bilimsel verilere ve literatüre dayalı olarak tartışılması amacıyla yapılmıştır.

Anahtar Kelimeler

• Aşılama
• Covid 19 enfeksiyonu
• gebelik
• laktasyon

VACCINATION AGAINST COVID 19 INFECTION DURING PREGNANCY AND LACTATION: A BRIEF REVIEW

Öz

Objective: Vaccination plays a crucial role in the protection against the Covid 19 infection. However, pregnant and lactating women are excluded from clinical trials of vaccines due to the unknown effects of the vaccine on the expectant mother, fetus, and infant. Pregnancy and the following lactation periods are long processes with unique physiological, psychological, and pathological characteristics, in which many practices are discussed for the mother and the baby. Based on the limited data available on the mechanisms of action of vaccine types, Covid 19 vaccines cannot possibly cause any risk to pregnant women and nursing mothers. On the other hand, there is currently insufficient data on the safety of Covid 19 vaccines in pregnant and lactating women. Result and Discussion: Evidence-based and personalized information about vaccines is needed to support pregnant and breastfeeding women's decision-making about vaccines. Vaccination should be recommended to all pregnant and lactating women after they have been sufficiently informed about the advantage and risks of Covid 19 vaccines and their consent has been obtained. This brief review was conducted to discuss vaccination against Covid 19 infection during pregnancy and the lactation period based on scientific data and literature.

Anahtar Kelimeler

• Covid 19 infection
• lactation
• pregnancy
• vaccination

Kaynakça

1. 1. Public Health England Web site (2020). Retrieved May, 2020, from https://www.gov.uk/government/ publications/wuhan-novel-coronavirus-background-information/wuhan-novel-coronavirus-epidemiology-virology-and-clinicalfeatures/. Accessed date: 29.06.2021.
2. 2. National Health Service Web site (2020). Retrieved May, 2020, from https://www.nhs.uk/conditions/coro naviruscovid-19/. Accessed date: 29.06.2021.
3. 3. World Health Organisation. Web site (2019). Retrieved May, 2019, from https://www.who.int/emergencies /diseases/novelcoronavirus-2019/. Accessed date: 29.06.2021.
4. 4. World Health Organisation Web site (2019). Retrieved May, 2020, from https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020/. Accessed date: 29.06.2021.
5. 5. Karaca, B. (2020). Erişkin yaş grubunda COVID-19 klinik bulguları. Journal of Biotechnology and Strategic Health, 4, 85-90. [CrossRef]
6. 6. Günal, Z., Türe, E., Bayburtlu, M., Arslan, U., Demirağ, M.D., Taşkın, M.H., Kılıç, S. (2020). COVID-19 tanılı hastaların risk faktörleri açısından değerlendirilmesi. Mikrobiyoloji Bülteni, 54(4), 575-582.
7. 7. Ulutaşdemir, N., Kulakaç N. (2021). COVID-19 Pandemisinde Sağlık Hizmetleri II. Edt., İKSAD Yayınevi, Ankara, syf.90.
8. 8. Maternal and Fetal Medicine and Perinatalogy Society Türkiye Web site (2020). Retrieved June, 2021, from https://www.tmftp.org/files/Duyurular/blglndrm_3.pdf/. Accessed date: 05.01.2021.

9. 9. Rasmussen, S.A., Smulian, J.C., Lednicky, J.A., Wen, T.S., Jamieson, D.J. (2020). Coronavirus disease 2019 (COVID-19) and pregnancy: What obstetricians need to know. American Journal of Obstetrics and Gynecology, 222(5), 415-426. [CrossRef]
10. 10. Abbas-Hanif, A., Rezai, H., Ahmed, S.F., Ahmed, A. (2022). The impact of COVID-19 on pregnancy and therapeutic drug development. British Journal of Pharmacology, 179(10), 2108-2120. [CrossRef]
11. 11. ACOG Web site (2020). Retrieved May, 2020, from https://www.acog.org/clinical/clinical-guidance/ practice-advisory/articles/2020/12/covid-19-vaccination-considerations-for-obstetric-gynecologic-care/. Accessed date: 29.06.2021.
12. 12. Maternal and Fetal Medicine and Perinatalogy Society Türkiye Web site (2021). Retrieved June, 2021, from https://www.tmftp.org/files/uzman-gorusleri/gebelerde_covid19_asisi.pdf/. Accessed date: 29.06. 2021.
13. 13. Wong, S.F., Chow, K.M., Leung, T.N., Ng, W.F., Ng, T.K., Shek, C.C., Ng, P.C., Lam, P.W., Ho, L.C., To, W.W., Lai, S.T., Yan, W.W., Tan, P.Y. (2004). Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. American Journal of Obstetrics and Gynecology, 191(1), 292-297.
14. 14. CDC Web site (2019). Retrieved June, 2021, from https://www.cdc.gov/coronavirus/2019-ncov/vaccines/ recommendations/pregnancy.html/. Accessed date: 29.06.2021.
15. 15. Poon, L.C., Yang, H., Lee, J.C.S., Copel, J.A., Leung, T.Y., Zhang, Y., Chen, D., Prefumo, F. (2020). ISUOG interim guidance on 2019 novel coronavirus infection during pregnancy and puerperium: Information for healthcare professionals. Ultrasound in Obstetrics & Gynecology, 55(5), 700-708. [CrossRef]
16. 16. RxMediaPharma Web site (2020). Retrieved May, 2020, from https://www.rxmpws.com/. Accessed date: 20.02.2023.
17. 17. Chen, S., Huang, B., Luo, D.J., Li, X., Yang, F., Zhao, Y., Nie, X., Huang, B.X. (2020). Zhonghua bing li xue za zhi. Chinese Journal of Pathology, 49(5), 418-423.
18. 18. Unicef Web site (2019). Retrieved June, 2019, from https://www.unicef.org/nutrition/files/Collective_ Advocacy_Brief_Breastfeeding_and_ HIV_Final_January_2019.pdf/. Accessed date: 29.06.2021.
19. 19. Cochrane Web site (2019). Retrieved June, 2019, from https://pregnancy.cochrane.org/news /covid-19-review-national-clinical-practice-guidelines-key-questions-relating-carepregnan/. Accessed date: 06.07. 2021.
20. 20. Haykır, N. (2020). Emzirme ve COVID-19 pandemisi. Southern Clinics of Istanbul Eurasia, 31(Suppl), 74-77.
21. 21. World Health Organisation Web site (2019). Retrieved May, from https://www.who.int/emergencies/disea ses/novel-coronavirus-2019/question-and-answers-hub/q-adetail/q-a-on-covid-19pregnancyandchildbirth/. Accessed date: 03.07.2021.
22. 22. Unicef Web site (2021). Retrieved June, 2019, from https://www.unicef.org/turkey/hikayeler/covid-19-salg%C4%B1n%C4%B1-s%C4%B1ras%C4%B1nda-g%C3%BCvenli-emzirme/. Accessed date: 29.06. 2021.
23. 23. Republic of Türkiye Ministry of Health Web site (2021). Retrieved July, 2021, from https://covid19asi. saglik.gov.tr/TR-77708/covid-19-asisi-cesitleri.html/ Accessed date: 11.07.2021.
24. 24. Republic of Türkiye Ministry of Health Web site (2021). Retrieved July, 2021, from https://covid19asi.saglik.gov.tr/TR-77709/covid-19-asisi-uretim-teknolojileri.html/. Accessed date: 11.07. 2021.
25. 25. CDC Web site (2021). Retrieved August, 2021, from https://www.cdc.gov/coronavirus/2019-ncov/ vaccines/different-vaccines/janssen.html/. Accessed date: 10.08.2021.
26. 26. BionTech Web site (2021). Retrieved July, 2021, from https://impfung.biontech.de/tr/mechanism-of-mrna/. Accessed date: 11.07.2021.
27. 27. Shimabukuro, T.T., Kim, S.Y., Myers, T.R., Moro, P.L., Oduyebo, T., Panagiotakopoulos, L., Marquez, P. L., Olson, C.K., Liu, R., Chang, K.T., Ellington, S.R., Burkel, V.K., Smoots, A.N., Green, C.J., Licata, C., Zhang, B.C., Alimchandani, M., Mba-Jonas, A., Martin, S.W., Gee, J.M. CDC v-safe COVID-19 Pregnancy Registry Team (2021). Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons. The New England Journal of Medicine, 384(24), 2273-2282. [CrossRef]
28. 28. CDC Web site (2022). Retrieved January, 2022, from https://www.cdc.gov/vaccines/covid-19/clinical-considerations/covid-19-vaccines-us.html/. Accessed date: 05.01.2022.
29. 29. Maertens, K., Orije, M.R.P., Van Damme, P., Leuridan, E. (2020). Vaccination during pregnancy: current and possible future recommendations. European Journal of Pediatrics, 179(2), 235-242. [CrossRef]
30. 30. Zaman, K., Roy, E., Arifeen, S.E., Rahman, M., Raqib, R., Wilson, E., Omer, S.B., Shahid, N.S., Breiman, R.F., Steinhoff, M.C. (2008). Effectiveness of maternal influenza immunization in mothers and infants. The New England Journal of Medicine, 359(15), 1555-1564. [CrossRef]
31. 31. Dereli, F., Ağartıoğlu Kundakçı, G., Yıldırım, J.G., Uyanık, G., Yılmaz, M. (2021). Aile sağlığı merkezine başvuran gebelerin bağışıklama durumlarının belirlenmesi. İzmir Katip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi, 6(2), 77-83.
32. 32. Sezerol, M.A., Davun, S. (2023). COVID-19 vaccine hesitancy and related factors among unvaccinated pregnant women during the pandemic period in Turkey. Vaccines, 11(1), 132. [CrossRef]
33. 33. Maternal and Fetal Medicine and Perinatalogy Society Türkiye Web site (2021). Retrieved June, 2021, from https://www.tmftp.org/files/sunumlar/23-nisan-2015/aliirfankutlar_pm2015.pdf/. Accessed date: 07. 06.2021.
34. 34. Badell, M.L., Dude, C.M., Rasmussen, S.A., Jamieson, D.J. (2022). Covid-19 vaccination in pregnancy. BMJ (Clinical research ed.), 378, e069741.
35. 35. Luxi, N., Giovanazzi, A., Capuano, A., Crisafulli, S., Cutroneo, P.M., Fantini, M.P., Ferrajolo, C., Moretti, U., Poluzzi, E., Raschi, E., Ravaldi, C., Reno, C., Tuccori, M., Vannacci, A., Zanoni, G., Trifirò, G., Ilmiovaccino COVID19 collaborating group (2021). COVID-19 vaccination in pregnancy, paediatrics, immunocompromised patients and persons with history of allergy or prior SARS-CoV-2 infection: Overview of current recommendations and pre- and post-marketing evidence for vaccine efficacy and safety. Drug Safety, 44(12), 1247-1269.
36. 36. Zambrano, L.D., Ellington, S., Strid, P., Galang, R.R., Oduyebo, T., Tong, V.T., Woodworth, K.R., Nahabedian, J.F., 3rd, Azziz-Baumgartner, E., Gilboa, S.M., Meaney-Delman, D., CDC COVID-19 response pregnancy and infant linked outcomes team (2020). Update: Characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status-United States. Morbidity and Mortality Weekly Report, 69(44), 1641-1647.
37. 37. United States of America State of North Dakota official Web site 2021. Retrieved January, 2021, from https://www.health.nd.gov/sites/www/files/documents/COVID%20Vaccine%20Page/COVID-19_Vaccine_FAQ_General_Public.pdf/. Accessed date: 05.01.2022.
38. 38. Magnus, M.C., Örtqvist, A.K., Dahlqwist, E., Ljung, R., Skår, F., Oakley, L., Macsali, F., Pasternak, B., Gjessing, H.K., Håberg, S.E., Stephansson, O. (2022). Association of SARS-CoV-2 vaccination during pregnancy with pregnancy outcomes. JAMA, 327(15), 1469-1477. [CrossRef]
39. 39. Duran, S. (2008). Tıpta Uzmanlık Tezi. Ebe ve hemşirelerin anne sütü ve emzirme konusundaki bilgi ve tutumlarının, danışmanlık verdikleri annelerin bebeklerini anne sütü ile besleme davranışlarına etkisi. Aile Hekimliği Anabilim Dalı, Tıp Fakültesi, Trakya Üniversitesi, Edirne, Türkiye.
40. 40. American Academy of Pediatrics. (1997). Breast feding and the use of human milk. Pediatrics, 100, 1035.
41. 41. Muyldermans, J., De Weerdt, L., De Brabandere, L., Maertens, K., Tommelein, E. (2022). The effects of COVID-19 vaccination on lactating women: A systematic review of the literature. Frontiers in Immunology, 13, 852928. [CrossRef]
42. 42. Royal College of Obstetricians and Gynaecologists Web site (2021). Retrieved July, 2021, from https://www.rcog.org.uk/en/guidelines-research-services/coronavirus-covid-19-pregnancy-and-womens-health/covid-19-vaccines-and-pregnancy/covid-19-vaccines-pregnancy-and-breastfeeding/. Accessed date: 29.06.2021.
43. 43. Goverment of UK Web site (2021). Retrieved June, 2021, from https://www.gov.uk/government/ publications/covid-19-vaccination-women-of-childbearing-age-currently-pregnant-planning-a-pregnancy-or-breastfeeding/covid-19-vaccination-a-guide-for-women-of-childbearing-age-pregnant-planning-apregn ancy-or-breastfeeding/. Accessed date: 29.06.2021.
44. 44. Moderna Web site (2020). Retrieved November, 2020, from https://investors.modernatx.com/news/news-details/2020/Moderna-Announces-Primary-Efficacy-Analysis-in-Phase-3-COVE-Study-for-Its-COVID-19-Vaccine-Candidate-and-Filing-Today-with-U.S.-FDA-for-Emergency-UseAuthorization/default.aspx/. Accessed date: 07.02.2021.
45. 45. Clinical Trials Web site (2022). Retrieved January, 2022, from https://clinicaltrials.gov/ct2/show /NCT04754594/. Accessed date: 05.01.2022.
46. 46. Republic of Türkiye Ministry of Health Web site (2021). Retrieved July, 2021, from https://covid19asi.saglik.gov.tr/TR-78082/inaktif-covid-19-asisi-gebelere-uygulanabilir-mi.html#:~:text= Gebelikte%20inaktif%20COVID%2D19%20a%C5%9F%C4%B1s%C4%B1n%C4%B1n,kendi%20istekleri%20halinde%20a%C5%9F%C4%B1%20uygulanabilir/. Accessed date: 29.06.2021.
47. 47. Goverment of UK Web site (2021). Retrieved June, 2021, from https://www.gov.uk/government/ publications/safety-of-covid-19-vaccines-when-given-in-pregnancy/the-safety-of-covid-19-vaccines-whe n-given-in-pregnancy/. Accessed date: 29.06.2021.